COO Cooper Companies Earnings and EPS analysis

?
Relative Growth: Rel. Growth: 44
Relative Strength: Rel. Strength: 29
Relative Valuation: Rel. Valuation: 31
Relative Profitability: Rel. Profitability: 50

EPS in 2026 (TTM): $1.19

Last Report Period Date: Apr 30, 2026

According to the most recent financial data from April 2026, the EPS for the trailing twelve months is $1.19. Cooper Companies's EPS for 2025 amounted to $1.88, marking a drop from $1.97 in 2024. During the quarterly period ending on Apr 30, 2026, COO's EPS stood at -$0.4.

COO earnings history

Historical annual and quarterly earnings per share (EPS) data for Cooper Companies
EPS (TTM)
$1.19
EPS Growth YoY (Quarterly)
-190.9%
EPS (Quarterly)
-$0.4
EPS Growth (Quarterly)
-159.7%

Cooper Companies had an annual EPS of $1.88, indicating a drop of 4.6% from $1.97 in 2024. The quarterly per-share earnings for the period ending Apr 30, 2026, was -$0.4, indicating a 190.9% decrease from the same quarter last year. COO's 12-month EPS stands at $1.19 as of April 2026. Cooper Companies's annual EPS in 2024 stood at $1.97, a 32.2% increase year-over-year.

COO earnings chart

COO EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
-190.9%
EPS growth YoY
-4.6%
EPS growth 3Y avg
-1.2%
EPS growth 5Y avg
9.2%

During the last 12 months, Cooper Companies has seen an EPS growth of -190.9% (YoY, quarterly). Examining a broader timeline, the company maintained an average EPS growth rate of -1.2% per year for the last three years. During the last 5 years, the company had an average EPS growth rate of 9.2%. A 10-year view shows that COO has seen an average EPS growth of 6% per year.

COO Earnings Waterfall

Breakdown of revenue, profit and net income for Cooper Companies

COO Earnings vs Peers

What are the earnings of COO compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
UTMD Utah Medical Products Inc 20.01 -12.1% -8.4% 3.4%
BSX Boston Scientific Corp 20.15 55.6% 63.3% N/A
NVS Novartis AG 21.25 21.8% 31.2% 15.2%
JNJ Johnson & Johnson 26.66 90.6% 17.7% 14.8%
COO Cooper Companies Inc 56.59 -4.6% -1.2% 9.2%
TFX Teleflex Inc N/A -1,462.4% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.